Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
27.24
+0.18 (0.67%)
At close: Mar 9, 2026, 4:00 PM EDT
27.24
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:10 PM EDT
Genmab Market Cap
Genmab has a market cap or net worth of $16.46 billion as of March 9, 2026. Its market cap has increased by 10.79% in one year.
Market Cap
16.46B
Enterprise Value
20.12B
1-Year Change
10.79%
Ranking
Category
Stock Price
$27.24
Market Cap Chart
Since April 23, 2012, Genmab's market cap has increased from $420.50M to $16.46B, an increase of 3,813.35%. That is a compound annual growth rate of 30.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 17.38B | -12.10% |
| Dec 31, 2025 | 19.78B | 43.19% |
| Dec 31, 2024 | 13.81B | -34.35% |
| Dec 29, 2023 | 21.04B | -24.60% |
| Dec 30, 2022 | 27.90B | 7.47% |
| Dec 31, 2021 | 25.96B | -1.89% |
| Dec 31, 2020 | 26.46B | 84.27% |
| Dec 31, 2019 | 14.36B | 35.31% |
| Dec 31, 2018 | 10.61B | -0.44% |
| Dec 29, 2017 | 10.66B | -0.04% |
| Dec 30, 2016 | 10.66B | 23.74% |
| Dec 31, 2015 | 8.62B | 128.70% |
| Dec 31, 2014 | 3.77B | 49.72% |
| Dec 31, 2013 | 2.52B | 179.56% |
| Dec 31, 2012 | 900.30M | 114.10% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Moderna | 20.74B |
| Roivant Sciences | 20.60B |
| Revolution Medicines | 19.50B |
| Incyte | 19.09B |
| Ascendis Pharma | 14.77B |
| BridgeBio Pharma | 12.67B |
| Ionis Pharmaceuticals | 12.23B |
| BioMarin Pharmaceutical | 11.75B |